At a glance
ClinicalIndex Comparison RecordN/ACompleted· 5,139 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Sapienza University Mortality and Morbidity Events Rate (SUMMER) Study in Diabetes: Identification of New Molecular Promoters of Mortality and Morbidity in Patients With Type 2 Diabetes Mellitus
In Brief
An observational study for Type 2 Diabetes Mellitus. Completed, enrolled 5,139 participants across 1 site.
Detailed Summary
This observational study is aimed at identifying new molecular promoters of mortality (and morbidity) in patients with type 2 diabetes mellitus (T2DM).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes Mellitus
CountriesItaly
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartJan 2014
First PostedDec 2014
Primary CompletionDec 2020
Study CompletionDec 2022
TodayJul 2026
First PostedDec 8, 2014
Enrollment StartJan 1, 2014
Primary CompletionDec 1, 2020
Study CompletionDec 1, 2022
TodayJul 2, 2026
Enrollment to primary: 6.9 yearsPosted 11.6 years ago